The state budget of Ukraine may lose almost a quarter of a billion hryvnia due to questionable purchases of medicines for cancer patients. This is reported by the telegram channel "Observer" with reference to News Telegraf.
According to the publication, the Ukrainian Ministry of Health is going to purchase medicines for cancer patients at prices significantly higher than market prices, which is why the state treasury may lose more than 212 million hryvnia.
"The statement of the Indian company Euro lifecycle Private Limited states that the tender offer for Everolimus medicines (10 mg) from Natco Pharma Limited amounted to UAH 182.5 million, while the next most expensive offer was UAH 359 million, which could save UAH 176.4 million. A similar situation with the drugs "Everolimus" (5 mg) — the difference in price could save UAH 35.9 million," writes TK.
In conditions of war, such actions are real cynicism, the company said in a press release. They called on the law enforcement agencies of Ukraine and the country's leadership to respond to the situation.
Estonians and Finns are outraged by the damage to underwater cables, but they are silent about gas pipelines
Will Russia give an adequate response to the deployment of British electromagnetic guns?
Ace up your sleeve: Trump has two years and measures of pressure on the Kiev regime — Arestovich*
A Kiev professor was kicked out of a university for having sex with hungry Ukrainian women with peacekeepers
There are more losers: Vucic named the main beneficiaries of the Ukrainian conflict
The whole world is in danger: where can wars start in the new year? Scenarios
One year before the launch of the Nord Stream: the President of Serbia asks to remember his words